- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Elagolix.
Displaying page 1 of 1.
EudraCT Number: 2011-004295-11 | Sponsor Protocol Number: M12-671 | Start Date*: 2013-07-15 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis- Associated Pain | |||||||||||||
Medical condition: Moderate to Severe Endometriosis Associated Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) AT (Completed) IT (Completed) HU (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-001047-31 | Sponsor Protocol Number: M12-821 | Start Date*: 2014-05-14 | |||||||||||
Sponsor Name:AbbVie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: Extension Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Subjects with Moderate to Severe Endometriosis-Associated Pain | |||||||||||||
Medical condition: Moderate to Severe Endometriosis Associated Pain | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: CZ (Completed) GB (Completed) AT (Completed) IT (Completed) ES (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003131-16 | Sponsor Protocol Number: 20584 | Start Date*: 2021-01-25 | |||||||||||
Sponsor Name:Bayer AG | |||||||||||||
Full Title: A randomized, double-blind, open for active comparator, parallel-group, multicenter Phase 2b study to assess the efficacy and safety of three different doses of P2X3 antagonist (BAY 1817080) versus... | |||||||||||||
Medical condition: Treatment of pain related to endometriosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) CZ (Completed) SK (Completed) FI (Completed) NO (Completed) AT (Completed) LT (Completed) PL (Completed) BE (Completed) BG (Prematurely Ended) HU (Completed) GR (Completed) EE (Completed) LV (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000082-37 | Sponsor Protocol Number: M12-813 | Start Date*: 2013-12-23 | |||||||||||
Sponsor Name:Abbvie Deutschland GmbH & Co. KG | |||||||||||||
Full Title: A Phase 2b Study to Evaluate the Safety and Efficacy of Elagolix in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids | |||||||||||||
Medical condition: Heavy menstrual bleeding associated with uterine fibroids | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006474-28 | Sponsor Protocol Number: NBI-56418-0703 | Start Date*: 2008-05-14 | |||||||||||
Sponsor Name:Neurocrine Biosciences, INC | |||||||||||||
Full Title: A Phase II, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Assess the Efficacy and Safety of NBI-56418 in Subjects with Endometriosis | |||||||||||||
Medical condition: Endometriosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) PL (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.